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In 84% of cases the magnitude ofbactertmia in children 
is >5  CFU/mL [l] and a small volume of blood 
(1-3 mL) appears to be sufficient for blood culture in 
this age group [2-4]. Here, we report our experience 
in sepsis-risk children in evaluating the clinical usefiil- 
ness of a pediatric blood culture method based on a 
blood/broth ratio of 1 : 41 and a continuously monitor- 
ing blood culture system-BacT/Alert (Organon 
Teknika Corp., Durham, NC, USA). The UacTlAlert 
blood culture set consisted of aerobic and anaerobic 
standard bottles (40 mL of culture medium in each 
case). Blood samples were obtained from children by 
the pediatric junior medical staff using standard aseptic 
technique: 1 niL of blood was distributed by needle and 
syringe to each bottle in the BacTIAlert standard blood 
culture set. The aerobic bottle was vented before 
loading in the BacT/Alert system to equalize the 
internal pressure: the other remained anaerobic. These 
bottles were incubated at 35°C for 7 days under con- 
tinuous shaking and monitoring conditions. Blood 
cultures drawn after 5 I’M were kept at  room tenipera- 
ture until 7 AM the next morning. Gram stains were 
made on smears from positive bottles and subcultures 
were made on appropriate agar plates. Isolates were 
identified and tested for antibiotic susceptibility by 
standard methods [ 51. 
Between September 1992 and October 1994, 
sepsis-risk patients with BacT/Alert standard blood 
culture sets were enrolled in the study. Blood specimens 
from patients receiving systemic antimicrobial treat- 
ment and promptly incubated were included in an 
‘early entry-on therapy’ group (EON). Blood culture 
sets collected more than 8 h before incubation in which 
the antibiotic coverage was lacking were recorded in a 
‘delayed entry-off therapy’ group (DEOFF). The blood 
culture sets from patients not receiving systemic anti- 
microbial chemotherapy and that had been promptly 
incubated were recorded in ‘early entry-off therapy’ 
group (EOFF). The blood culture sets not included in 
the above mentioned groups were not considered for 
this study. Sepsis was defined according to the terms 
and definition proposed by the American College of 
Chest PhysiciandSociety of Critical Care Medicine 
Consensus Conference [6]. The clinical signs and 
laboratory test results included fever, leukocytosis, 
neutropenia, elevated ratio of immature to total neutro- 
phils (I/T ratio), apneic and bradycardic episodes, 
feeding intolerance, and increased oxygen require- 
ments. In addition, if the’ child responded to the 
appropriate antibiotic therapy the diagnosis of sepsis 
was considered confirmed. 
The relevance (cause of sepsis or contaminant) of 
a microorganism isolated was based on the number of 
times it was recovered from multiple blood cultures, the 
clinical signs in the patient, and the response of the 
patient to antimicrobial therapy. A contaminant was 
defined as an isolate that was recovered from a culture 
of the blood but was not deemed responsible for the 
clinical signs and symptoms that prompted the blood 
culture. Data were retrieved froin a database (Access 2.0 
Microsoft). All analysis was performed with statistical 
software packages (StatView 4.1 Abacus Concepts Inc., 
Berkeley, CA). Parainetric data were compared by the 
use of ANOVA. A relationship between two nominal 
variables was investigated by means of contingency 
table analyses. A probability of <0.01 was considered 
significant. 
During the period, 2582 blood culture sets which 
met the protocol’s criteria were included in the study. 
These specimens were obtained from 1010 children 
(479 female and 531 male), median age 2.7 months 
(range 0-143). A positive blood culture was found in 
410 of the 2582 (15.9%) specimens that were cultured. 
False-positive results occurred in 21 (0.8%); for 20 of 
these 21, the detection time was greater than 5 days. 
Routine terminal subculture of negative blood culture 
sets was carried out on the first 617 sets; no false 
negatives were detected. Positive cultures were more 
common in those aged 0-34 months (285 observed 
versus 234 expected) and lower in those more than 34 
months (119 versus 170) (Fisher’s exact test; p <  
0.0001). In the ‘DEOFF’ group, comprising 763 blood 
culture sets (26.6% of total), a positive blood culture 
was found in 136 (17.8%), with a mean detection tinie 
of 29.2 h (95% confidence interval 23.2-37.1); the 
‘EON’ group was made up of796 blood culture sets 
(30.8% of total) and a positive blood culture was found 
in 116 (14.6%), with a mean detection time of 37.0 h 
(95% confidence interval 29.0-45.0). Finally, the 
‘EOFF’ group comprised 1023 blood culture sets with 
158 positive blood cultures (15.4%) and the mean 
detection time was 28.1 h (95% confidence interval 
23.3-32.8). The effects of different conditions before 
processing were studied, and no significant difference 
was described for the rate of positive blood culture 
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Table 1 Summarv table of blood culture results 
~~ 
Observed frequencies 
(no of cultures) 
EOFF DEOFF EON 
Expected value\ 
(no. of cultures) Post hoc cell contributions 





158 136 116 
865 627 680 
71 87 94 
87 49 22 
~ 
162.4 121.2 126.4 -0.5 1.8 -1.2 
860.6 641.8 669.6 0.5 -1.8 1.2 
97.1 83.6 71.3 -5.4 0.7 5.1 
60.9 52.4 44.7 5.4 -0.7 -5.1 
_ _ _ _ _ ~  
EOFF: promptly incubated, no antimicrobial chemotherapy 
DEOFF: collected more than 8 h before incubation, no antimicrobial chemotherapy. 
EON: promptly incubated and on antimicrobial chemotherapy. 
(chi-square; p=0.1899) (Table 1) and for the time 
to positivity detection (ANOVA; 11’0.8297). O f  410 
positive blood cultures, 252 (8.8% of all submitted 
cultures) were deemed clinically significant (1 52 epi- 
sodes of sepsis from 98 patients). Contaminated blood 
cultures were found in 158 sets (6.1% of all submitted 
cultures). As shown in Table 1, the ‘EON’ group had 
a higher number of pathogens and the ‘EOFF’ group a 
higher number of contaminants (chi-square; p<0.0001). 
The microorganisms causing sepsis are shown in Figure 
1. As shown in Figure 2, the pathogens’ mean positivity 
time was 19.1 h (95% confidence interval 14.3-23.8); 
in contrast, the contaminants’ mean time to positivity 
was 43.5 h (95% confidence interval 24.0-63.0) 
(ANOVA; p=0.0056). 
All of the clinically important organisms were 
detected within 24 h. Most of the children included in 
the study came from neonatal intensive care unit and 
surgery wards; this explains the high positivity rate of 
blood cultures (15.9%), and also the fact that coagulase- 
negative staphylococci were common clinically signi- 
ficant isolates, particularly Staphylococcus epidermidis. In 
the ‘DEOFF’ group, where there had been a substantial 
delay in processing, we did not detect any significant 
difference fi-om the groups containing cultures incubated 
promptly. This feature is of primary importance when 
blood cultures have to be processed in a laboratory with 
8-10-h technologist cover. In the ‘EON’ group, which 
included patients suspected of being septic, and 
receiving antibiotics as prophylaxis, we did not observe 
Figure 1 Distribution of organisms causing 152 episodes of sepsis in 98 children. CNS, coagulase-negatgive staphylococci. 
‘Others’ group includes one viridans group streptococcus, one Bacteroidesfragilis, one mixed Gram-negative rods and Gram- 
positive cocci. 









Figure 2 Box plot of mean positivity time for pathogens 
and contaminants (95% confidence band about median). 
a fall in the yield of organisms; in fact, this group had 
the largest number of clinically significant positive 
cultures. Our protocol, using as small a blood volume 
as 1 mL and a dilution factor of 1 :41, appears to be a 
valid choice to demonstrate bloodstream infection in 
patients under 34 months of age. 
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The incidence of nosocomial infections caused by 
Enterococcus spp. has increased dramatically in recent 
years. In fact, Enterococcus spp. are currently among 
the leading causes of nosocomial infection [I]. The 
emergence of enterococci resistant to glycopeptides, 
the increase in high-level resistance of aminoglycosides, 
the production of P-lactamase by certain strains and 
the intrinsic resistance of enterococci to several anti- 
microbials serve to limit the therapeutic options for the 
treatment of infections caused by these microorganisms 
PI ' 
Commercially available fluoroquinolones are not 
very useful for the treatment of infections caused by 
enterococci [3]. In recent years, new fluoroquinolones 
have been developed offering a broader spectrum 
and higher activity against Gram-positive cocci. The 
purpose of this study is to evaluate the activity of 
classical and new fluoroquinolones against clinical 
isolates of Enterococcns spp. 
For this study, 100 consecutively collected clinical 
isolates of Enterococcus faecalis (50) and E. faclcium (50) 
were obtained from blood cultures (54), urine samples 
(32) and other clinical specimens (14) from different 
patients in the University Hospital of Seville during 
1995 and 1996. All strains were identified by both 
standard methods [4] and the API 20 STREP 
(BioMbrieux; France). 
The minimum inhibitory concentrations (MICs) 
of norfloxacin (Sigma, USA), ciprofloxacin (Bayer, 
Germany), sparfloxacin (Sigma, USA), ofloxacin 
(Hoechst, Germany), levofloxacin (Roussel, France), 
pefloxacin (Rhone-Poulenc, France), trovafloxacin 
(Pfizer, USA), clinafloxacin (Parke-Davis, USA) and 
